RSC Advances
Paper
the corresponding Gnucleoside 8 as white solid material 7.43 (1H, C6–H), 7.40–6.79 (13H, DMT), 5.13–5.06 (1H, C20–H),
(155 mg, 69%). Rf ¼ 0.42 (CHCl3–MeOH 9 : 1, v/v); FAB MS: calc. 4.16–4.15 (2H, C10–H), 4.08–4.05 (2H, P–O–CH2C–S), 3.75 (6H, 2
for C8H11N5O3 225.2, found: 226.2 (+VE), 224.1 (ꢀVE).
Iso-butyrylation of GG – synthesis of compound 9
ꢂ OCH3), 3.33–3.25 (2H, C30–H), 1.89–1.20 (3H, C5–CH3; 10H,
–(CH2)5–“spiro”); 13C NMR d (CDCl3, ppm) 162.6, 157.3, 143.0,
140.0, 134.2, 128.7, 126.7, 126.6, 125.7, 111.9, 78.0, 76.4, 75.7,
75.1, 62.2, 53.9, 36.0, 35.3, 23.9, 22.7, 22.2, 11.0. 5a OTP-GT slow:
Rf ¼ 0.60 (CHCl3–MeOH 9 : 1, v/v); Rt ¼ 21.5 min (EtOAc–hexane
50 : 50, v/v); MALDI TOF MS: calc. for C36H41N2O7PS2 708.8
found: 747.6 ((+); 708.8 + K+); 31P NMR d (CDCl3, ppm) 106.1; 1H
NMR d (CDCl3, ppm) 8.37 (1H, N3–H), 7.40 (1H, C6–H), 7.32–
6.79 (13H, DMT), 5.09–5.02 (1H, C20–H), 4.16–4.11 (2H, C10–H),
4.08–4.05 (2H, P–O–CH2C–S), 3.77 (6H, 2 ꢂ OCH3), 3.38–3.19
(2H, C30–H), 1.86–1.20 (3H, C5–CH3; 10H, –(CH2)5–“spiro”); 13C
NMR d (CDCl3, ppm) 162.6, 157.3, 149.5, 139.8, 128.7, 126.8,
126.7, 111.9, 76.4, 75.7, 75.1, 53.9, 35.7, 23.9, 22.4, 1.0. 5b
OTP-GABz fast: Rf ¼ 0.72 (CHCl3–MeOH 9 : 1, v/v); Rt ¼ 18 min
(EtOAc–hexane 45 : 55, v/v); MALDI TOF MS calc. 821.9 found
822.6 (+); 31P NMR d (CDCl3, ppm) 105.8; 1H NMR d (CDCl3,
ppm) 8.95 (1H, NHCO), 8.75 (1H, C8–H), 8.02 (1H, C2–H), 7.54–
6.78 (18H, DMT, Bz), 5.22–5.15 (1H, C20–H), 4.57–4.54 (2H, C10–
H), 4.08–3.98 (2H, P–O–CH2C–S), 3.77 (6H, 2 ꢂ OCH3), 3.32–
3.30 (2H, C30–H), 1.61–1.23 (10H, –(CH2)5–“spiro”); 13C NMR
d (CDCl3, ppm) 155.0, 140.5, 128.8, 126.3, 124.2, 113.7, 109.4,
75.8, 51.2, 21.2, 20.0, 19.6. 5b OTP-GABz slow: Rf ¼ 0.58 (CHCl3–
MeOH 9 : 1, v/v); Rt ¼ 23 min (EtOAc–hexane 45 : 55, v/v);
MALDI TOF MS calc. 821.9 found 822.6 (+); 31P NMR d (CDCl3,
ppm) 106.6; 1H NMR d (CDCl3, ppm) 8.95 (1H, NHCO), 8.75 (1H,
C8–H), 8.03 (1H, C2–H), 7.54–6.79 (18H, DMT, Bz), 5.23–5.19
(1H, C20–H), 4.56–4.55 (2H, C10–H), 4.09–4.03 (2H, P–O–CH2C–
S), 3.77 (6H, 2 ꢂ OCH3), 3.31–3.30 (2H, C30–H), 1.56–1.21 (10H,
–(CH2)5–“spiro”); 13C NMR d (CD3CN, ppm) 157.5, 143.4, 142.9,
134.1, 128.8, 126.7, 116.0, 111.8, 78.1, 62.1, 53.6, 34.7, 23.5, 22.3.
5c OTP-GCBz fast: Rf ¼ 0.70 (CHCl3–MeOH 9 : 1, v/v); Rt ¼ 27 min
(EtOAc–hexane 55 : 45, v/v); MALDI TOF MS calc. 797.9 found
799.0 (+); 31P NMR d (CDCl3, ppm) 105.1; 1H NMR d (CDCl3,
ppm) 8.70 (1H, NHCO), 7.88–7.85 (2H, C6–H, C5–H), 7.60–6.79
(18H, DMT, Bz), 5.26–5.22 (1H, C20–H), 4.20–4.15 (2H, C10–H),
To a solution of 8 (225 mg, 1 mmol) in anhydrous pyridine (30
mL) trimethylsilyl chloride (1.01 mL, 8 mmol) was added at 0 ꢃC.
The reaction mixture was stirred at 0 ꢃC for 15 min, followed by
ꢃ
40 min at room temperature. The mixture was cooled to 0 C
and iso-butyryl anhydride (415 mL, 2.5 mmol) was added drop-
wise. The mixture was allowed to warm slowly to room
temperature and was stirred for 2 h. The reaction was stopped
by addition of H2O (2 mL) at 0 ꢃC. Aer 10 min, conc. NH4OH (2
mL) was added and the mixture was le for 15 min. The volatile
components were removed in vacuo. The residue was dissolved
in MeOH, loaded onto a silica gel column and the column was
eluted with EtOAc, EtOAc–MeOH (9 : 1, v/v), and nally with
EtOAc–MeOH (9 : 2, v/v) to yield 239 mg (81%) of GGiBu. Rf ¼
0.10 (CHCl3–MeOH 9 : 1, v/v); FAB MS: calc. for C12H17N5O4
295.3, found: 296.1 (+VE), 294.2 (ꢀVE).
Dimethoxytritylation of 9 – synthesis of DMT-GG (compound
4d)
To a solution of 9 (295 mg, 1 mmol) in anhydrous pyridine (4
mL) solid DMT-Cl (406 mg, 1.2 mmol) was added at room
temperature. Aer 2 h, the reaction mixture was concentrated in
vacuo. The residue was puried by chromatography on a silica
gel column, rst eluted with hexane–EtOAc–Et3N (1 : 2 : 0.01, v/
v/v), then with EtOAc–Et3N (100 : 1, v/v), and nally with EtOAc–
DMT-
MeOH–Et3N (25 : 1 : 0.01, v/v/v). The fraction containing
GGiBu (Rf ¼ 0.46 (CHCl3–MeOH 9 : 1, v/v)) was concentrated in
vacuo to yield 430 mg (colorless foam, 72%); FAB MS: calc. for
C
33H35N5O6 597.7 found: 296,1 ([M-DMT]+; +VE).
HPLC separation of P-diastereomers of GNA
oxathiaphospholane monomers 5a–d
A preparative HPLC silica gel column (Pursuit XRs 10 mm, 250 ꢂ 4.10–4.04 (2H, P–O–CH2C–S), 3.76 (6H, 2 ꢂ OCH3), 3.43–3.28
21.2 mm) was equilibrated with a given eluent mixture (see (2H, C30–H), 1.61–1.20 (10H, –(CH2)5–“spiro”); 13C NMR
Table 1) at a ow rate 25 mL minꢀ1 for 20 minutes. A solution of d (CDCl3, ppm) 161.0, 157.3, 148.6, 143.0, 134.2, 134.0, 131.9,
5 (100 mg; 300 mg for 5a) in ethyl acetate (1.5 mL, with 1% TEA) 128.7, 127.8, 126.8, 126.6, 112.0, 85.1, 78.1, 67.7, 62.2, 59.1, 53.9,
was ltered through a membrane lter (0.2 mm pores, organic 50.9, 36.2, 35.2, 23.9, 22.7, 22.2, 12.9. 5c OTP-GCBz slow: Rf ¼
solvent resistant) and the ltrate was applied onto the column. 0.58 (CHCl3–MeOH 9 : 1, v/v); Rt ¼ 31.2 min (EtOAc–hexane
The column was eluted at the ow rate of 25 mL minꢀ1 and 55 : 45, v/v); MALDI TOF MS calc. 797.9 found 799.1 (+); 31P
1
baseline separation of P-diastereomers was achieved. The NMR d (CDCl3, ppm) 105.7; H NMR d (CDCl3, ppm) 8.70 (1H,
collected fractions were concentrated using a rotary evaporator NHCO), 7.84–7.82 (2H, C6–H, C5–H), 7.60–6.80 (18H, DMT, Bz),
with a “cold nger” condenser lled with isopropyl alcohol/dry 5.30–5.21 (1H, C20-H), 4.33–4.26 (2H, C10–H), 4.18–4.08 (2H, P–
ice coolant, with the temperature of a water bath not exceeding O–CH2C–S), 3.77 (6H, 2 ꢂ OCH3), 3.43–3.21 (2H, C30–H), 1.61–
30 ꢃC. Pure P-diastereomers were recovered in ca. 90% and their 1.20 (10H, –(CH2)5–“spiro”); 13C NMR d (CDCl3, ppm) 172.2,
diastereomeric purity was conrmed by 31P NMR analysis 157.3, 148.4, 131.9, 128.8, 127.7, 126.8, 126.6, 126.2, 111.9, 77.9,
(CDCl3, an estimated limit of detection of a minor component 76.4, 75.7, 75.1, 53.9, 50.8, 35.5, 23.9, 22.5, 22.4. 5d OTP-GGiBu
1
0.2%). They gave satisfactory H NMR, 31P NMR, 13C NMR and fast: Rf ¼ 0.65 (CHCl3–MeOH 9 : 1, v/v); Rt ¼ 13.5 min (EtOAc–
MALDI-TOF mass spectra.
hexane 85 : 15, v/v); MALDI TOF MS calc. 803.9 found 804.6 (+);
1
5a OTP-GT fast: Rf ¼ 0.68 (CHCl3–MeOH 9 : 1, v/v); Rt ¼ 31P NMR d (CDCl3, ppm) 106.1; H NMR d (CDCl3, ppm) 11.89
19.2 min (EtOAc–hexane 50 : 50, v/v); MALDI TOF MS: calc. for (1H, NHCO), 8.34 (1H, N1–H), 7.58 (1H, C8–H), 7.24–6.76 (13H,
C
36H41N2O7PS2 708.8 found: 747.6 (+); 708.8 + K+); 31P NMR DMT), 5.17–5.10 (1H, C20–H), 4.41–4.31 (2H, C10–H), 4.08–3.94
d (CDCl3, ppm) 105.6; 1H NMR d (CDCl3, ppm) 8.36 (1H, N3–H), (2H, P–O–CH2C–S), 3.76 (6H, 2 ꢂ OCH3), 3.17–3.15 (2H, C30–H),
24950 | RSC Adv., 2018, 8, 24942–24952
This journal is © The Royal Society of Chemistry 2018